UGDH and metabolic dysfunction-associated steatotic liver disease: In addition, UGDH levels were not altered in primary hepatocytes after exposure to palmitic acid, which was performed to mimic in vivo NAFLD pathologies (Supplementary Fig. 1j), suggesting that the decline of UGDH expression in livers with NAFLD is not attributed to the accumulation of palmitate per se.